Remove Doctors Remove Patients Remove Side effects
article thumbnail

As FDA puts CAR-T safety under microscope, researchers dig into adverse events record of BCMA therapies

Fierce Pharma

BCMA-targeted therapies are transforming care for multiple myeloma patients. But these immunotherapies also come with various potentially dangerous side effects. |

article thumbnail

Why This Doctor Now Prescribes Generics

Contrarian Sales Techniques

Beyond the Brand Name Dr. Elena Reyes was a doctor's doctor. For over two decades, her patients in the quaint town of Harmony Springs trusted her implicitly. One of the things her patients appreciated most was her reliance on brand-name medications. What if there were unseen side effects?

Doctors 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UK agency pilots biobank to study links between genetics and drug side effects

Pharmaceutical Technology

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. Side effects due to drugs are responsible for one in every 16 hospital admissions in the UK, based on the announcement.

article thumbnail

Medical Sales Strategies: How to Drive Doctors’ Recommendations

MaBiCo

Medical Sales Strategies: How to Drive Doctors’ Recommendations Medical sales are a set of activities and skills whose purpose is to influence health care professionals to recommend or prescribe a product. Selling to private practice doctors is different than selling to healthcare organizations.

article thumbnail

Um, about that diabetes drug that helped patients lose weight

World of DTC Marketing

Yet the media has led with “diabetes drug leads to major weight loss” Will doctors inform patients? Wegovy’s most common side effects were gastrointestinal problems, including nausea, diarrhea, and vomiting, which 80% of patients reported, according to USA Today.

article thumbnail

Novo’s obesity drug has serious warnings and barriers to overcome

World of DTC Marketing

SUMMARY: The media headlines promise weight loss for diabetes patients, but Norvo’s new drug is in the same class as other drugs and carries many warnings. Can diabetes patients really stay adherent to a drug for 63 weeks in which 85% of patients report GI side effects and will insurance cover the cost?

article thumbnail

Experts flag eye inflammation reports tied to Apellis' geographic atrophy med Syfovre

Fierce Pharma

The news sent Apellis' share price down 32% to $52.62 by Monday afternoon.